KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardlytics (CDLX) Common Equity (2016 - 2025)

Cardlytics' Common Equity history spans 10 years, with the latest figure at -$6.5 million for Q4 2025.

  • For Q4 2025, Common Equity fell 109.3% year-over-year to -$6.5 million; the TTM value through Dec 2025 reached -$6.5 million, down 109.3%, while the annual FY2025 figure was -$6.5 million, 109.3% down from the prior year.
  • Common Equity reached -$6.5 million in Q4 2025 per CDLX's latest filing, down from -$4.7 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $744.9 million in Q1 2021 to a low of -$6.5 million in Q4 2025.
  • Average Common Equity over 5 years is $319.8 million, with a median of $218.5 million recorded in 2022.
  • Peak YoY movement for Common Equity: surged 447.57% in 2021, then plummeted 109.3% in 2025.
  • A 5-year view of Common Equity shows it stood at $690.7 million in 2021, then tumbled by 69.36% to $211.6 million in 2022, then plummeted by 36.3% to $134.8 million in 2023, then tumbled by 48.08% to $70.0 million in 2024, then tumbled by 109.3% to -$6.5 million in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Common Equity are -$6.5 million (Q4 2025), -$4.7 million (Q3 2025), and $58.7 million (Q2 2025).